We study the controllable optical response in a three-mode optomechanical system comprised of two indirectly coupled cavity modes and an intermediate mechanical mode. The two cavity modes are assumed to have different frequencies and driven by two control fields on the red and blue sidebands, respectively. When the system is perturbed by two probe fields satisfying the specific matching condition, a series of intriguing phenomena can be observed by adjusting phases and amplitudes of the control fields, such as absorption-amplification switching, ultra-narrow response windows, frequency-independent perfect reflection, and ultralong optical group delay. We also compare our system with conventional optomechanical systems to highlight its distinct features. Our results may have potential applications in optical communication and quantum information processing.

Download full-text PDF

Source
http://dx.doi.org/10.1364/OE.27.021843DOI Listing

Publication Analysis

Top Keywords

controllable optical
8
optical response
8
response three-mode
8
three-mode optomechanical
8
optomechanical system
8
cavity modes
8
control fields
8
system
4
system driving
4
driving cavities
4

Similar Publications

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease associated with neuroinflammation and heightened production of reactive oxygen species (ROS) in the brain from overactive NADPH Oxidase 2 (NOX2). The current study examines whether administration of a novel, brain-penetrant NOX2 inhibitor (CPP11G & CPP11H) reduces amyloid plaque load and improves AD-associated vascular dysfunction in a male APP-PS1 mouse model of AD.

Method: Intraperitoneal injections of CPP11G (n = 1) or CPP11H (n = 2) three times per week began at 9-10 months of age in the treatment APP-PS1 group (15 mg/kg).

View Article and Find Full Text PDF

Background: Effect of dynamic lighting on sleep were studied since 1980's. Traditional light sources were used due to lack of advancement in technology and also researchers assumed illuminance as cause of melatonin suppression. This led researchers to use high illuminance to suppress melatonin at day time.

View Article and Find Full Text PDF

Background: Alzheimer's disease can cause sleep disturbances in humans, which can worsen other symptoms of the disease.

Method: In our study, we examined the sleep patterns of 23 patients with Alzheimer's disease, aged 65-74 years (20 women and 3 men), over 4 months. All patients reported experiencing poor sleep, including difficulty sleeping in the ward, frequent awakenings during the night, early morning awakenings, and daytime sleepiness.

View Article and Find Full Text PDF

Background: This presentation maps the journey of an evidence-based dementia care program from effectiveness trial design to adoption by policymakers as an ongoing program available to eligible older adults living at home with dementia and their care partners. Care of People with Dementia in their Environments (COPE) is a non-pharmacologic program that seeks to maximize physical function and quality of life in people with dementia and build dementia management skills in care partners. Efficacy trial results showed that, compared to controls, people with dementia receiving COPE had greater functional independence in activities of daily living and care partners receiving COPE reported improved well-being and increased confidence using dementia management skills.

View Article and Find Full Text PDF

Background: Phenotyping Alzheimer's Disease (AD) can be crucial to providing personalized treatment. Several studies have analyzed the use of digital biomarkers to characterize a subject's behavior, usually obtained from a single modality, such as speech. However, combining several modalities in a single study has not been deeply studied.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!